Event Videos

https://www.ncbi.nlm.nih.gov/pubmed/30083892
Primary sclerosing cholangitis

Curr Gastroenterol Rep. 2018 Aug 6;20(9):44. doi: 10.1007/s11894-018-0649-2.
Post-Transplant Disease Recurrence in Pediatric PSC.
Soufi N1, Bazerbachi F2, Deneau M3.
Author information

Abstract

PURPOSE OF REVIEW:
Review the current knowledge about recurrent primary sclerosing cholangitis (rPSC) after transplant in children.

RECENT FINDINGS:

Published on: 
Aug-2018

https://www.ncbi.nlm.nih.gov/pubmed/30156739 Biliary Atresia

Hepatol Res. 2018 Aug 29. doi: 10.1111/hepr.13245. [Epub ahead of print]
CYP7A1 expression in hepatocytes is retained with upregulated fibroblast growth factor 19 in pediatric biliary atresia.
Hasegawa Y1, Kawai M2, Bessho K1, Yasuda K1, Ueno T3, Satomura Y1, Konishi A1, Kimura T1, Ikeda K1, Tachibana M1, Miyoshi Y1, Michigami T2, Kondou H1,4, Ozono K1.

Abstract

AIM:

Published on: 
Aug-2018

https://www.ncbi.nlm.nih.gov/pubmed/30159619

Eur Radiol. 2018 Aug 29. doi: 10.1007/s00330-018-5697-3. [Epub ahead of print]
Intrahepatic cystic biliary dilatation constitutes a significant prognostic factor in patients with primary sclerosing cholangitis.
Nguyen L1, Cazzagon N2,3, Corpechot C2, El Mouhadi S1, Lemoinne S2, Chazouillères O2, Arrivé L4,5.

Abstract

AIMS:
To evaluate the prognostic value of cystic dilatation (CD) of the intrahepatic biliary ducts in patients with primary sclerosing cholangitis (PSC).

METHODS:

Published on: 
Aug-2018

https://www.ncbi.nlm.nih.gov/pubmed/30166220

Dig Liver Dis. 2018 Aug 3. pii: S1590-8658(18)30870-3. doi: 10.1016/j.dld.2018.07.033. [Epub ahead of print]

Pediatric autoimmune liver disease and extra-hepatic immune-mediated comorbidities.
Paolella G1, Farallo M1, Degrassi I1, Agostoni C1, Amoruso C1, Nuti F1, Nebbia G2.

Abstract

BACKGROUND:
Autoimmune liver disease (AILD) includes autoimmune hepatitis (AIH) and autoimmune sclerosing cholangitis (ASC). AILD is often associated with other extra-hepatic immune-mediated disorders (EDs), but there are few pediatric studies available to date. In this study we evaluated the association between AILD and EDs in our pediatric series.

METHODS:

Published on: 
Aug-2018

https://www.ncbi.nlm.nih.gov/pubmed/30117178 Portal hypertension

J Ultrasound Med. 2018 Aug 16. doi: 10.1002/jum.14764. [Epub ahead of print]
Diagnostic Performance of Ultrasound Elastography for Evaluating Portal Hypertension in Children: A Systematic Review and Meta-analysis.
Kim DW1, Yoon HM2, Jung AY2, Lee JS2, Oh SH3, Kim KM3, Cho YA2.

Abstract

OBJECTIVES:
To assess the diagnostic performance of ultrasound (US) elastography in evaluating portal hypertension in children and compare the liver and spleen stiffness values between the portal hypertension and control groups.

METHODS:

Published on: 
Aug-2018

https://www.ncbi.nlm.nih.gov/pubmed/30168073 Hepatitis E

Indian J Gastroenterol. 2018 Aug 31. doi: 10.1007/s12664-018-0878-1. [Epub ahead of print]
Pegylated interferon-based sequential therapy for treatment of HBeAg reactive pediatric chronic hepatitis B-First study in children..Lal BB1, Sood V1, Khanna R1, Rawat D1, Verma S1, Alam S2.

Abstract

BACKGROUND:

Our aim was to evaluate the efficacy and safety of sequential therapy using pegylated interferon (Peg-IFN) and nucleos(t)ide analogue (NA) for treatment of children in immunoactive (IA) and immunotolerant (IT) phases of chronic hepatitis B.

METHODS:

Published on: 
Aug-2018

CLF Intro movie

Financial Aid Offered by Trusts

Follow us on: